Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia 4Neuroblastoma 3Myelodysplastic Syndromes 3Lymphoma, Non-Hodgkin 3Leukemia, Myeloid, Acute 3Wilms Tumor 2Testicular Neoplasms 2Sarcoma, Ewing 2Sarcoma 2Rhabdomyosarcoma 2Medulloblastoma 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hodgkin Disease 2Brain Neoplasms 2Astrocytoma 2Teratoma 1Retinoblastoma 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Philadelphia Chromosome 1Pathologic Complete Response 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroectodermal Tumors 1Multiple Myeloma 1Lymphoma, Large B-Cell, Diffuse 1

Interventions

Cyclophosphamide 61Rituximab 60Etoposide 28fludarabine phosphate 23Prednisone 23fludarabine 22Vincristine 19Filgrastim 19Doxorubicin 19ibrutinib 16Peripheral Blood Stem Cell Transplantation 16venetoclax 15Lenalidomide 14Bortezomib 14Carboplatin 13CT-P10 13Gemcitabine 12Vorinostat 11Cytarabine 11pembrolizumab 9Radiotherapy 9Melphalan 9Magnetic Resonance Spectroscopy 9Dexamethasone 9Bendamustine Hydrochloride 9Paclitaxel 8Ifosfamide 8Cyclosporine 8Biopsy 8Tacrolimus 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Lymphoma, Large B-Cell, Diffuse × Bone Marrow Transplantation × Clear all
NCT01497184 2025-03-13

Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood

M.D. Anderson Cancer Center

Phase 1 Completed
95 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡